OBJECTIVE: Infection is the most frequent cause of acute respiratory distress syndrome (ARDS). However, little is known about the influence of infection sites on ARDS. This study aimed to assess the associations of infection sites with ARDS development and mortality in critically ill infected patients. DESIGN: Prospective observational study. SETTING: Adult intensive care units (ICUs) of an academic medical center. PATIENTS: Study population included 1,973 consecutive patients admitted to ICUs with bacteremia, pneumonia or sepsis. During follow-up, 549 patients developed ARDS and 212 of them died within 60 days. MAIN RESULTS: The distribution of infection sites in ARDS patients was: lung (77.2%), abdomen (19.3%), skin/soft tissues (6.0%), urinary tract (4.7%), unknown (2.6%), and multiple sites (17.7%). On multivariate analysis, lung was the only infection site associated with increased ARDS risk [adjusted odds ratio (OR) 3.49]. Urinary tract (adjusted OR 0.43), skin/soft tissue (adjusted OR 0.64), and unknown-site infections (adjusted OR 0.38) were associated with decreased risk. No association was found between individual infection site and ARDS mortality. However, unknown-site [adjusted hazard ratio (HR) 3.08] and multiple-site infections (adjusted HR 1.63) were associated with increased ARDS mortality. When grouping patients into pulmonary, nonpulmonary, and combined infections, nonpulmonary infection was associated with decreased ARDS risk (adjusted OR 0.28) and combined infections was associated with increased ARDS mortality (adjusted HR 1.69), compared with pulmonary infection. CONCLUSIONS: In critically ill infected patients, pulmonary infection is associated with higher risk of ARDS development than are infections at other sites. Pulmonary versus nonpulmonary infection significantly affects ARDS development but not mortality.
OBJECTIVE: Infection is the most frequent cause of acute respiratory distress syndrome (ARDS). However, little is known about the influence of infection sites on ARDS. This study aimed to assess the associations of infection sites with ARDS development and mortality in critically ill infectedpatients. DESIGN: Prospective observational study. SETTING: Adult intensive care units (ICUs) of an academic medical center. PATIENTS: Study population included 1,973 consecutive patients admitted to ICUs with bacteremia, pneumonia or sepsis. During follow-up, 549 patients developed ARDS and 212 of them died within 60 days. MAIN RESULTS: The distribution of infection sites in ARDS patients was: lung (77.2%), abdomen (19.3%), skin/soft tissues (6.0%), urinary tract (4.7%), unknown (2.6%), and multiple sites (17.7%). On multivariate analysis, lung was the only infection site associated with increased ARDS risk [adjusted odds ratio (OR) 3.49]. Urinary tract (adjusted OR 0.43), skin/soft tissue (adjusted OR 0.64), and unknown-site infections (adjusted OR 0.38) were associated with decreased risk. No association was found between individual infection site and ARDS mortality. However, unknown-site [adjusted hazard ratio (HR) 3.08] and multiple-site infections (adjusted HR 1.63) were associated with increased ARDS mortality. When grouping patients into pulmonary, nonpulmonary, and combined infections, nonpulmonary infection was associated with decreased ARDS risk (adjusted OR 0.28) and combined infections was associated with increased ARDS mortality (adjusted HR 1.69), compared with pulmonary infection. CONCLUSIONS: In critically ill infectedpatients, pulmonary infection is associated with higher risk of ARDS development than are infections at other sites. Pulmonary versus nonpulmonary infection significantly affects ARDS development but not mortality.
Authors: Michael A Matthay; Guy A Zimmerman; Charles Esmon; Jahar Bhattacharya; Barry Coller; Claire M Doerschuk; Joanna Floros; Michael A Gimbrone; Eric Hoffman; Rolf D Hubmayr; Mark Leppert; Sadis Matalon; Robert Munford; Polly Parsons; Arthur S Slutsky; Kevin J Tracey; Peter Ward; Dorothy B Gail; Andrea L Harabin Journal: Am J Respir Crit Care Med Date: 2003-04-01 Impact factor: 21.405
Authors: Jason Phua; Joan R Badia; Neill K J Adhikari; Jan O Friedrich; Robert A Fowler; Jeff M Singh; Damon C Scales; David R Stather; Amanda Li; Andrew Jones; David J Gattas; David Hallett; George Tomlinson; Thomas E Stewart; Niall D Ferguson Journal: Am J Respir Crit Care Med Date: 2008-11-14 Impact factor: 21.405
Authors: Rama K Mallampalli; Tiffany A Coon; Jennifer R Glasser; Claire Wang; Sarah R Dunn; Nathaniel M Weathington; Jing Zhao; Chunbin Zou; Yutong Zhao; Bill B Chen Journal: J Immunol Date: 2013-10-11 Impact factor: 5.422
Authors: Mark J Mondrinos; Ting Zhang; Shuang Sun; Paul A Kennedy; Devon J King; Marla R Wolfson; Linda C Knight; Rosario Scalia; Laurie E Kilpatrick Journal: Am J Pathol Date: 2013-11-06 Impact factor: 4.307
Authors: Tiffany A Coon; Alison C McKelvey; Travis Lear; Shristi Rajbhandari; Sarah R Dunn; William Connelly; Joe Y Zhao; SeungHye Han; Yuan Liu; Nathaniel M Weathington; Bryan J McVerry; Yingze Zhang; Bill B Chen Journal: Sci Transl Med Date: 2015-07-08 Impact factor: 17.956
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2011-01-12 Impact factor: 17.440
Authors: Niki D Ubags; Juanita H Vernooy; Elianne Burg; Catherine Hayes; Jenna Bement; Estee Dilli; Lennart Zabeau; Edward Abraham; Katie R Poch; Jerry A Nick; Oliver Dienz; Joaquin Zuñiga; Matthew J Wargo; Joseph P Mizgerd; Jan Tavernier; Mercedes Rincón; Matthew E Poynter; Emiel F M Wouters; Benjamin T Suratt Journal: Crit Care Med Date: 2014-02 Impact factor: 7.598
Authors: Zhaozhong Zhu; Ruyang Zhang; Liming Liang; Li Su; Quan Lu; Andrea A Baccarelli; Ednan K Bajwa; B Taylor Thompson; David C Christiani Journal: Intensive Care Med Date: 2016-08-09 Impact factor: 17.440
Authors: A A R Thompson; R S Dickinson; F Murphy; J P Thomson; H M Marriott; A Tavares; J Willson; L Williams; A Lewis; A Mirchandani; P Dos Santos Coelho; C Doherty; E Ryan; E Watts; N M Morton; S Forbes; R H Stimson; A G Hameed; N Arnold; J A Preston; A Lawrie; V Finisguerra; M Mazzone; P Sadiku; J Goveia; F Taverna; P Carmeliet; S J Foster; E R Chilvers; A S Cowburn; D H Dockrell; R S Johnson; R R Meehan; M K B Whyte; S R Walmsley Journal: Sci Immunol Date: 2017-02-10
Authors: Marija Kojicic; Guangxi Li; Andrew C Hanson; Kun-Moo Lee; Lokendra Thakur; Jayanth Vedre; Adil Ahmed; Larry M Baddour; Jay H Ryu; Ognjen Gajic Journal: Crit Care Date: 2012-12-12 Impact factor: 9.097